Retinal Vessel Measurements as Clinically Useful Predictors in Veterans
Diabetic complications are an important source of blindness and mortality among veterans. Their occurrence is unpredictable because of the highly variable effect of factors such as weight, diet and exercise. Improved prediction of diabetes complications has the potential to improve the care for veterans with diabetes, especially if this can be done without any extra effort for the veterans or their caretakers. All veterans with diabetes in VHA are required to undergo annual retinal photography to screen for current diabetic retinopathy. We have recently developed an automated, precise, fast, novel tool for measuring retinal vessels in these images. Manual measurement of retinal vessels has shown that these can predict future -not current- development of hypertension and also diabetic retinopathy. If we can confirm that our tool can flag those veterans at increased risk for developing these diabetes complications, this will allow earlier intervention and prevention. Because the tool only uses the images that are being taken anyway, there is no extra effort for either the veteran or VA staff.
|Study Design:||Observational Model: Cohort
Time Perspective: Retrospective
|Official Title:||Retinal Vessel Measurements as Clinically Useful Predictors in Veterans|
- Area under the Curve of algorithm [ Time Frame: 2/1/2016 ] [ Designated as safety issue: No ]AUC of automatically derived retinal vessel parameters (arterial and retinal vessel width and branch relationships) as an early biomarker for future development of hypertension no less than 2 years later, with normal current normal blood pressure.
Biospecimen Retention: None Retained
Retinal images - vessel parameters
|Study Start Date:||February 2013|
|Estimated Study Completion Date:||February 2016|
|Estimated Primary Completion Date:||February 2016 (Final data collection date for primary outcome measure)|
500 veterans with diabetes, all of whom did not have hypertension at the time of imaging
retinal images from a population of 4000 veterans with diabetes, currently without DR, ~10% of who developed retinopathy no less than two years later while the remainder did not.
Background: We hypothesize that retinal vessel derived biomarkers, obtained using our automated, precise, fast, novel tool for measuring retinal vessels in retinal images can identify veterans at increased risk for diabetic retinopathy and hypertension, before any overt signs of retinopathy or increased blood pressure have become apparent. Population studies have shown that changes in arterial and venous diameter are associated with future development of these complications.
Purpose: Determine the potential utility of retinal vessel derived biomarkers, from color fundus photographs, as a non-invasive independent risk factor for diabetic retinopathy (DR) and hypertension in veterans with diabetes.
Methods: Aim 1. We will evaluate automatically derived retinal vessel parameters (arterial and retinal vessel width and branch relationships) as an early biomarker for future development of hypertension no less than 2 years later, with normal current normal blood pressure. We will compare this biomarker in retinal images from 500 veterans with diabetes, all of whom did not have hypertension at the time of imaging, for those who were and were not diagnosed with hypertension no more than 3 years later. Aim 2. To evaluate automatically derived retinal vessel parameters as an early biomarker for the risk for development of diabetic retinopathy (defined as transition from less than moderate retinopathy AND no apparent macular edema according to the International Clinical Diabetic Retinopathy and Diabetic Macular Edema Severity Scale) in at risk veterans with diabetes. We will compare this biomarker in retinal images from a population of 4000 veterans with diabetes, currently without DR, ~10% of who developed retinopathy no less than two years later while the remainder did not.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01772173
|Contact: Michael Abramoff, MD||Michael.Abramoff@va.gov|
|Contact: Kari A Steinkamp||(319) 338-0581 ext 7678||Kari.Steinkamp2@va.gov|
|United States, Iowa|
|Iowa City VA Health Care System, Iowa City, IA||Not yet recruiting|
|Iowa City, Iowa, United States, 52246-2208|
|Contact: Kari A Steinkamp 319-338-0581 ext 7678 Kari.Steinkamp2@va.gov|
|Contact: Mark A Yorek, PhD (319) 338-0581 ext 7666 firstname.lastname@example.org|
|Principal Investigator: Michael Abramoff, MD|
|Principal Investigator:||Michael Abramoff, MD||Iowa City VA Health Care System, Iowa City, IA|